Statement on study showing that US abortion bans restrict miscarriage care

Abortion   |   20 May 2026   |   1 min read

Share






Copied


Responding to a new study showing that abortion bans in the US are restricting how miscarriages are treated, Beth Schlachter, MSI Reproductive Choices’ Senior Director of External Relations and Advocacy, said:

“This study confirms what healthcare providers have been warning for years: abortion bans make pregnancy more dangerous. 

“Laws banning abortion and attempts to restrict access to mifepristone and misoprostol are denying people experiencing miscarriage the safest, most effective treatment options and forcing them to endure unnecessary risk, pain, and trauma.  

“What happens in the US also has global consequences, emboldening attacks on reproductive rights and access to essential medicines around the world. 

“Everyone deserves compassionate, evidence-based healthcare, yet access to essential reproductive care is increasingly determined by where someone lives. These restrictions will only deepen the suffering of people already experiencing the heartbreak of pregnancy loss.”


Note to Editor 

For interviews and further information please contact: 

Email: [email protected]  

Tel: +44 (0)7769 166 516  


Share






Copied

Related posts

News


15 May 2026   |   4 min read

MSI statement on U.S. legal actions to restrict access to mifepristone

A recent U.S. federal court ruling restricting access to mifepristone is not grounded in medical evidence and fuels

News


30 March 2026   |   2 min read

Statement on the reported waste of $9.7 million worth of USAID contraception

MSI statement on reports in the New York Times that $9.7m worth of USAID contraception has been left in a warehouse

News


20 March 2026   |   2 min read

MSI statement on UK funding cuts to sexual and reproductive healthcare

MSI’s statement, responding to the news that the UK’s FCDO will reduce global funding for sexual and reproductive